Drug Shortage Report for FLUMAZENIL INJECTION
| Report ID | 95165 |
| Drug Identification Number | 02266342 |
| Brand name | FLUMAZENIL INJECTION |
| Common or Proper name | Flumazenil |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | FLUMAZENIL |
| Strength(s) | 0.1MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 5mL |
| ATC code | V03AB |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2019-10-01 |
| Actual start date | |
| Estimated end date | 2019-10-31 |
| Actual end date | 2019-11-19 |
| Shortage status | Resolved |
| Updated date | 2020-01-16 |
| Company comments | Available Nov 19, 2019 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2019-10-01 | English | Compare |
| v2 | 2019-10-01 | French | Compare |
| v3 | 2019-10-01 | English | Compare |
| v4 | 2019-10-01 | French | Compare |
| v5 | 2019-10-02 | English | Compare |
| v6 | 2020-01-16 | English | Compare |
| v7 | 2020-01-16 | French | Compare |
Showing 1 to 7 of 7